Efficacy of Escherichia coli -derived recombinant human bone morphogenetic protein-2 in posterolateral lumbar fusion: an open, active-controlled, randomized, multicenter trial

Jae Hwan Cho(Seoul National University Hospital), Jumi Han(Daewoong Pharmaceutical (South Korea)), Kwang Bok Lee(Jeonbuk National University Hospital), Hyoungmin Kim(New Generation University College), Choon‐Ki Lee(Seoul National University Hospital), Jin S. Yeom(Seoul National University Bundang Hospital), Jae Jun Yang(Dongguk University Ilsan Hospital), Ho‐Joong Kim(Seoul National University Hospital), Bong‐Soon Chang(Seoul National University Hospital), Ki Hyoung Koo(Dongguk University Ilsan Hospital), Woo Dong Nam(Kangwon National University Hospital), Jae Hyup Lee, Kyung‐Soo Suk(Yonsei University), Chang Ju Hwang(Ulsan College)
The Spine Journal
June 23, 2017
Cited by 43


Related Papers